Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependency.

× No keyword cloud information.

6 in total

1. Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors: Susan M Grant; Rennie C Heel
Journal: Drugs Date: 1992-04 Impact factor: 9.546

2. GM-CSF, carboplatin, doxorubicin: a phase I study.

Authors: E A Poplin; D S Alberts; J J Rinehart; H O Smith; J A Neidhart; E M Hersh
Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333

Review 3. Methodological issues in antiemetic studies.

Authors: M Aapro
Journal: Invest New Drugs Date: 1993-11 Impact factor: 3.850

4. Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group.

Authors: W P Steward; J Verweij; R Somers; G Blackledge; M Clavel; A T Van Oosterom; B Greifenberg; J Soedirman; D Thomas; M Van Glabbeke
Journal: J Cancer Res Clin Oncol Date: 1991 Impact factor: 4.553

5. rhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU.

Authors: R Rampling; W Steward; J Paul; M A Macham; E Harvey; D Eckley
Journal: Br J Cancer Date: 1994-03 Impact factor: 7.640

6. Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneously.

Authors: A H Honkoop; K Hoekman; J Wagstaff; C J van Groeningen; J B Vermorken; E Boven; H M Pinedo
Journal: Br J Cancer Date: 1996-10 Impact factor: 7.640

6 in total